- Aug 2022
-
jamanetwork.com jamanetwork.com
-
Friedensohn, L., Levin, D., Fadlon-Derai, M., Gershovitz, L., Fink, N., Glassberg, E., & Gordon, B. (2022). Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel. JAMA. https://doi.org/10.1001/jama.2022.4425
-
-
khub.net khub.net
-
Andrews, N., Stowe, J., Kirsebom, F., Gower, C., Ramsay, M., & Lopez Bernal, J. (2021). Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: Test negative case-control study [Preprint]. Epidemiology. https://doi.org/10.1101/2021.11.15.21266341
Tags
- COVID-19
- lang:en
- Moderna
- booster
- effectiveness
- symptom
- Pfizer-BioNTech
- BNT162b2 vaccine
- England
- vaccine
- over 50s
- protection
- is:preprint
Annotators
URL
-
-
www.medrxiv.org www.medrxiv.org
-
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., & Milo, R. (2021). Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19 (p. 2021.10.07.21264626). https://doi.org/10.1101/2021.10.07.21264626
-
- Dec 2021
-
twitter.com twitter.com
-
Abraar Karan. (2021, December 9). “Participants who received a booster at least 5 months after a second dose of BNT162b2 had 90% lower mortality due to Covid-19 than participants who did not receive a booster.” #covid19 https://t.co/zmXHyE7Lqb [Tweet]. @AbraarKaran. https://twitter.com/AbraarKaran/status/1468849516199563265
-
- Oct 2021
-
www.nature.com www.nature.com
-
Barros-Martins, J., Hammerschmidt, S. I., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Dopfer-Jablonka, A., Heidemann, A., Ritter, C., Friedrichsen, M., Schultze-Florey, C., Ravens, I., Willenzon, S., Bubke, A., Ristenpart, J., Janssen, A., Ssebyatika, G., Bernhardt, G., Münch, J., … Behrens, G. M. N. (2021). Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nature Medicine, 1–5. https://doi.org/10.1038/s41591-021-01449-9
-
- Aug 2021
-
www.nejm.org www.nejm.org
-
Lopez Bernal, Jamie, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, et al. “Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.” New England Journal of Medicine 0, no. 0 (July 21, 2021): null. https://doi.org/10.1056/NEJMoa2108891.
-
- Jun 2021
-
www.nature.com www.nature.com
-
Liu, Jianying, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, et al. “BNT162b2-Elicited Neutralization of B.1.617 and Other SARS-CoV-2 Variants.” Nature, June 10, 2021, 1–5. https://doi.org/10.1038/s41586-021-03693-y.
-
- Dec 2020
-
www.biorxiv.org www.biorxiv.org
-
To generate the template for RNA synthesis, a DNA fragment encoding the SARS-CoV-2 P2 279 S protein (based on GenBank: MN908947), including the amino acid exchanges K986P and 280 V987P, was cloned into a starting plasmid vector with backbone sequence elements for 281 improved RNA stability and translational efficiency19,34
BNT162b2
-